Literature DB >> 4324865

Evidence for a cyclic nucleotide-phosphodiesterase with high specificity for cyclic uridine-3',5'-monophosphate in rat adipose tissue.

U Klotz, K Stock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4324865     DOI: 10.1007/bf01422021

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmakol


× No keyword cloud information.
  9 in total

Review 1.  THE ACTION OF EPINEPHRINE AND THE ROLE OF THE ADENYL CYCLASE SYSTEM IN HORMONE ACTION.

Authors:  E W SUTHERLAND; I OYE; R W BUTCHER
Journal:  Recent Prog Horm Res       Date:  1965

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Inhibition of cyclic-3',5'-nucleotide-phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs.

Authors:  W R Kukovetz; G Pöch
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

4.  The assay of adenosine 3',5'-cyclic monophosphate and guanosine 3',5'-cyclic monophosphate in biological materials by enzymatic radioisotopic displacement.

Authors:  G Brooker; L J Thomas; M M Appleman
Journal:  Biochemistry       Date:  1968-12       Impact factor: 3.162

5.  Properties of cyclic 3',5'-nucleotide phosphodiesterase from rat brain.

Authors:  W Y Cheung
Journal:  Biochemistry       Date:  1967-04       Impact factor: 3.162

6.  A cyclic 3',5'-nucleotide phosphodiesterase from heart with specificity for uridine 3',5'-phosphate.

Authors:  J G Hardman; E W Sutherland
Journal:  J Biol Chem       Date:  1965-09       Impact factor: 5.157

7.  Purification and properties of 3',5'-cyclic nucleotide phosphodiesterase from dog heart.

Authors:  K G Nair
Journal:  Biochemistry       Date:  1966-01       Impact factor: 3.162

8.  An effect of insulin on adipose-tissue adenosine 3':5'-cyclic monophosphate phosphodiesterase.

Authors:  E G Loten; J G Sneyd
Journal:  Biochem J       Date:  1970-11       Impact factor: 3.857

9.  Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine.

Authors:  R W BUTCHER; E W SUTHERLAND
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

  9 in total
  4 in total

1.  Rat adrenal cyclic nucleotide-phosphodiesterase; inhibition by drugs known to affect steroidogenesis.

Authors:  U Klotz; H Vapaatalo; K Stock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

2.  cUMP hydrolysis by PDE3B.

Authors:  Jessica Ostermeyer; Franziska Golly; Volkhard Kaever; Stefan Dove; Roland Seifert; Erich H Schneider
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-28       Impact factor: 3.000

3.  Heterogeneity of pulmonary endothelial cyclic nucleotide response to Pseudomonas aeruginosa ExoY infection.

Authors:  K A Morrow; R Seifert; V Kaever; A L Britain; S L Sayner; C D Ochoa; E A Cioffi; D W Frank; T C Rich; T Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-18       Impact factor: 5.464

4.  Analysis of substrate specificity and kinetics of cyclic nucleotide phosphodiesterases with N'-methylanthraniloyl-substituted purine and pyrimidine 3',5'-cyclic nucleotides by fluorescence spectrometry.

Authors:  Daniel Reinecke; Frank Schwede; Hans-Gottfried Genieser; Roland Seifert
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.